ABC Arbitrage SA Buys New Stake in Cigna Group $CI

ABC Arbitrage SA purchased a new position in shares of Cigna Group (NYSE:CI) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,048 shares of the health services provider’s stock, valued at approximately $1,455,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Brighton Jones LLC lifted its position in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares during the last quarter. Sivia Capital Partners LLC raised its stake in Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after acquiring an additional 109 shares in the last quarter. Concurrent Investment Advisors LLC raised its stake in Cigna Group by 1.6% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 5,068 shares of the health services provider’s stock worth $1,675,000 after acquiring an additional 81 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in Cigna Group by 9.3% in the second quarter. Allspring Global Investments Holdings LLC now owns 259,157 shares of the health services provider’s stock valued at $86,660,000 after acquiring an additional 22,145 shares during the last quarter. Finally, Sequoia Financial Advisors LLC grew its holdings in shares of Cigna Group by 19.5% during the second quarter. Sequoia Financial Advisors LLC now owns 7,740 shares of the health services provider’s stock worth $2,559,000 after purchasing an additional 1,265 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Trading Down 2.3%

Shares of CI stock opened at $287.58 on Wednesday. The company has a market capitalization of $76.82 billion, a P/E ratio of 12.97, a price-to-earnings-growth ratio of 1.02 and a beta of 0.27. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $275.46 and its two-hundred day moving average is $283.64. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the company earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is presently 27.23%.

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Several Wall Street firms raised price targets and reiterated buy ratings — Jefferies raised its target to $333 and TD Cowen to $338, signaling analyst confidence in upside and earnings power. Jefferies price target raise TD Cowen price target raise
• Positive Sentiment: Deutsche Bank also nudged its target higher to $304 and kept a buy rating, reinforcing consensus analyst support. Deutsche Bank raise
• Positive Sentiment: Zacks highlighted CI as a top-ranked value stock under its style scores, which supports a longer‑term buy case based on valuation metrics. Zacks analysis
• Neutral Sentiment: Mixed analyst notes published via AmericanBankingNews show conflicting target moves (one note cites a raise to $297 while another reports RBC cutting its target to $333) — overall analyst momentum is positive but not uniform. RBC cut to $333 Price target to $297
• Negative Sentiment: MarketWatch flagged that CI underperformed its competitors on the session, suggesting sector rotation or short‑term selling pressure versus peers as a driver of the share decline. MarketWatch underperformance
• Negative Sentiment: Reports that Cigna will cut roughly 2,000 jobs introduce near‑term uncertainty about execution and could be read as a sign of operational stress even though layoffs may reduce costs over time. Beckers report on layoffs

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CI. Leerink Partners boosted their target price on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. UBS Group reaffirmed a “buy” rating and set a $375.00 price target on shares of Cigna Group in a research report on Monday. Wolfe Research reduced their price objective on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, October 15th. Wells Fargo & Company lowered their target price on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research report on Wednesday, November 5th. Finally, Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $330.00.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.